Evidence map›Paper›PMID 35971662›Full record

ArticleBrain and behavior2022

Molecular and histological correlates of cognitive decline across age in male C57BL/6J mice.

Rachel Britton, Angela T Liu, Sanket V Rege, Julia M Adams, Lily Akrapongpisak, David Le, Raniel Alcantara-Lee, Raul A Estrada, Rebecca Ray, Sara Ahadi and 6 more

Open access · goldAbstract read
In one paragraph

Article in Brain and behavior, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 5 institutions in 3 countries.

Rachel BrittonAlkahest, Inc., San Carlos, California, USA.ORCID 0000-0001-6741-4927
Angela T LiuAlkahest, Inc., San Carlos, California, USA.
Sanket V RegeAlkahest, Inc., San Carlos, California, USA.
Julia M AdamsAlkahest, Inc., San Carlos, California, USA.
Lily AkrapongpisakAlkahest, Inc., San Carlos, California, USA.
David LeAlkahest, Inc., San Carlos, California, USA.
Raniel Alcantara-LeeAlkahest, Inc., San Carlos, California, USA.
Raul A EstradaAlkahest, Inc., San Carlos, California, USA.
Rebecca RayAlkahest, Inc., San Carlos, California, USA.
Sara AhadiAlkahest, Inc., San Carlos, California, USA.
Ian GallagerAlkahest, Inc., San Carlos, California, USA.
Cindy F YangAlkahest, Inc., San Carlos, California, USA.
S Sakura MinamiAlkahest, Inc., San Carlos, California, USA.
Steven P BraithwaiteAlkahest, Inc., San Carlos, California, USA.
Eva CzirrAlkahest, Inc., San Carlos, California, USA.
Meghan Kerrisk CampbellAlkahest, Inc., San Carlos, California, USA.ORCID 0000-0003-4906-7743
Universidad San Carlos · PYAtara Biotherapeutics (United States) · USLC Resources (United States) · USThe University of Queensland · AUVistaGen Therapeutics (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionIncreasing age is the number one risk factor for developing cognitive decline and neurodegenerative disease. Aged humans and mice exhibit numerous molecular changes that contribute to a decline in cognitive function and increased risk of developing age-associated diseases. Here, we characterize multiple age-associated changes in male C57BL/6J mice to understand the translational utility of mouse aging.

methodsMale C57BL/6J mice from various ages between 2 and 24 months of age were used to assess behavioral, as well as, histological and molecular changes across three modalities: neuronal, microgliosis/neuroinflammation, and the neurovascular unit (NVU). Additionally, a cohort of 4- and 22-month-old mice was used to assess blood-brain barrier (BBB) breakdown. Mice in this cohort were treated with a high, acute dose of lipopolysaccharide (LPS, 10 mg/kg) or saline control 6 h prior to sacrifice followed by tail vein injection of 0.4 kDa sodium fluorescein (100 mg/kg) 2 h later.

resultsAged mice showed a decline in cognitive and motor abilities alongside decreased neurogenesis, proliferation, and synapse density. Further, neuroinflammation and circulating proinflammatory cytokines were increased in aged mice. Additionally, we found changes at the BBB, including increased T cell infiltration in multiple brain regions and an exacerbation in BBB leakiness following chemical insult with age. There were also a number of readouts that were unchanged with age and have limited utility as markers of aging in male C57BL/6J mice.

conclusionsHere we propose that these changes may be used as molecular and histological readouts that correspond to aging-related behavioral decline. These comprehensive findings, in the context of the published literature, are an important resource toward deepening our understanding of normal aging and provide an important tool for studying aging in mice.

Indexed as

Cognitive DysfunctionNeurodegenerative DiseasesAgingAnimalsCytokinesFluoresceinHippocampusLipopolysaccharidesMaleMiceMice, Inbred C57BLCytokinesFluoresceinLipopolysaccharidesagingbehaviorblood-brain barrierhippocampusneuroinflammationT lymphocytes

Identifiers

PMID35971662
PMCPMC9480918
OpenAlexW4292056900

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.